AcryMed is touting their latest innovation in wound healing: Dissolved oxygen delivery, via their Oxygenesys system:
Our research shows that these new devices deliver significant amounts of dissolved oxygen, which is the biologically relevant form” said Dr. Bruce Gibbins, Founder and Chief Technical Officer at AcryMed. “We conducted studies on human donor skin to show for the first time that through Oxygenesys TDO, sufficient oxygen penetrates deep into tissues to make up for the oxygen deficiency … read more
Topical Oxygen Therapy in Wound Care: OxyGenesys and AcryMed Update
An update from the Journal of Wound Care revisits topical oxygen therapies like OxyGenesys and AcryMed’s Microlattice, which aimed to enhance chronic wound healing. Their innovations continue to inform modern wound care practices.
Key Highlights:
- OxyGenesys: Delivered dissolved oxygen to wounds, but clinical trials showed limited healing improvements.
- AcryMed’s Microlattice: Supported oxygen delivery, complementing its SilvaSorb silver dressings for infection control.
- Clinical Impact: Both FDA-cleared technologies addressed chronic wounds, shaping oxygen therapy research.
- Current Relevance: Their work guides clinicians toward advanced antimicrobial and oxygen-based treatments.
This update highlights OxyGenesys and AcryMed’s lasting influence on wound care innovation.
Learn more about topical oxygen therapy in the Journal of Wound Care.
Keywords:
Oxygen therapy,
OxyGenesys,
AcryMed,
SilvaSorb,
Chronic wounds